Notice: This company has been marked as potentially delisted and may not be actively trading. NeuBase Therapeutics (NBSE) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisInsider TradesSustainabilityTrends NeuBase Therapeutics (NASDAQ:NBSE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.90%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$106,058.48Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$325,510.56 Get NBSE Insider Trade Alerts Want to know when executives and insiders are buying or selling NeuBase Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NBSE Insider Buying and Selling by Quarter Remove Ads NeuBase Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/14/2023Corp SymetryxMajor ShareholderSell129,108$1.44$185,915.52 9/11/2023Corp SymetryxMajor ShareholderSell3,376$1.44$4,861.44 9/7/2023Corp SymetryxMajor ShareholderSell74,852$1.80$134,733.60 9/1/2023Corp SymetryxMajor ShareholderBuy61,076$0.98$59,854.48 3/30/2022William Roland MannCOOBuy310$38.40$11,904.00 3/18/2022Todd P BranningCFOBuy500$36.20$18,100.00 3/16/2022Todd P BranningCFOBuy500$32.40$16,200.00 (Data available from 1/1/2013 forward) NBSE Insider Trading Activity - Frequently Asked Questions Who is on NeuBase Therapeutics's Insider Roster? The list of insiders at NeuBase Therapeutics includes Corp Symetryx, Todd P Branning, and William Roland Mann. Learn more on insiders at NBSE. What percentage of NeuBase Therapeutics stock is owned by insiders? 7.90% of NeuBase Therapeutics stock is owned by insiders. Learn more on NBSE's insider holdings. Which NeuBase Therapeutics insiders have been buying company stock? The following insider purchased NBSE shares in the last 24 months: Corp Symetryx ($59,854.48). How much insider buying is happening at NeuBase Therapeutics? Insiders have purchased a total of 61,076 NBSE shares in the last 24 months for a total of $59,854.48 bought. Which NeuBase Therapeutics insiders have been selling company stock? The following insider sold NBSE shares in the last 24 months: Corp Symetryx ($325,510.56). How much insider selling is happening at NeuBase Therapeutics? Insiders have sold a total of 207,336 NeuBase Therapeutics shares in the last 24 months for a total of $325,510.56 sold. NeuBase Therapeutics Key ExecutivesMr. Todd P. Branning (Age 54)Interim CEO, CFO & Secretary Compensation: $427.44kDr. Dietrich A. Stephan Ph.D. (Age 54)Founder, President & Director Compensation: $836.58k More Insider Trading Tools from MarketBeat Related Companies EVOK Insider Buying SNGX Insider Buying FRTX Insider Buying GTBP Insider Buying GLTO Insider Buying VRPX Insider Buying KZIA Insider Buying ADIL Insider Buying CERO Insider Buying SONN Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Companies Buying Back Stock—Why It MattersInsider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for Investors This page (NASDAQ:NBSE) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…Crypto 101 Media | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuBase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuBase Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
